Intervention not reported
ASCVD event, such as fatal or non‐fatal myocardial infarction or stroke. Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention showed no clear difference in ASCVD event, such as fatal or non‐fatal myocardial infarction or… (low certainty).
1 finding from 1 review
Intervention not reported
Any investigator‐defined adverse event Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention probably leads to higher any investigator‐defined adverse event Median (moderate certainty).
1 finding from 1 review
Intervention not reported
Systolic blood pressure, mmHg Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
1 finding from 1 review
Intervention not reported
Total cholesterol, mmol/L Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
1 finding from 1 review
Intervention not reported
LDL cholesterol, mmol/L Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
1 finding from 1 review
Intervention not reported
Adherence, variable definitions Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention probably leads to higher adherence, variable definitions Median (moderate certainty).
1 finding from 1 review
Intervention not reported
LDL‐cholesterol atorvastatin 10 mg/d · individuals with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐cholesterol atorvastatin 20 mg/d · individuals with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐cholesterol atorvastatin 40 mg/d · individuals with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐cholesterol atorvastatin 80 mg/d · individuals with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
WDAEb all doses · individuals with normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐Cholesterol rosuvastatin 2.5 mg/day · participantswith normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐Cholesterol rosuvastatin 5 mg/day · participantswith normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐Cholesterol rosuvastatin 10 mg/day · participantswith normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐Cholesterol rosuvastatin 20 mg/day · participantswith normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
LDL‐Cholesterol rosuvastatin 40 mg/day · participantswith normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
WDAE2 all doses · participantswith normal or abnormal lipid profiles
1 finding from 1 review
Intervention not reported
Outcomes per woman · couples with an in vitro fertilisation indication
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Miscarriage · couples with an in vitro fertilisation indication
The intervention showed no clear difference in miscarriage (moderate certainty).
1 finding from 1 review
Intervention not reported
Ongoing pregnancy · couples with an in vitro fertilisation indication
The intervention may leads to lower ongoing pregnancy (low certainty).
1 finding from 1 review